chr19-43018935-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002785.3(PSG11):āc.544A>Gā(p.Met182Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,612,146 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002785.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSG11 | NM_002785.3 | c.544A>G | p.Met182Val | missense_variant | 3/6 | ENST00000320078.12 | NP_002776.3 | |
PSG11 | NM_001113410.2 | c.178A>G | p.Met60Val | missense_variant | 2/5 | NP_001106881.1 | ||
PSG11 | NM_203287.2 | c.178A>G | p.Met60Val | missense_variant | 2/5 | NP_976032.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSG11 | ENST00000320078.12 | c.544A>G | p.Met182Val | missense_variant | 3/6 | 2 | NM_002785.3 | ENSP00000319140 | P2 | |
PSG11-AS1 | ENST00000635495.1 | n.182+41291T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151358Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251202Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135756
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1460670Hom.: 2 Cov.: 34 AF XY: 0.0000495 AC XY: 36AN XY: 726616
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151476Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74024
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.544A>G (p.M182V) alteration is located in exon 3 (coding exon 3) of the PSG11 gene. This alteration results from a A to G substitution at nucleotide position 544, causing the methionine (M) at amino acid position 182 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at